Clinical Trial Update: Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the safety and efficacy of Lapaquistat Acetate alone and in combination with atorvastatin in adults with primary dyslipidemia. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Lapaquistat Acetate (lapaquistat acetate)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Takeda | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED